Pelvic floor exercises are more effective in subjective and objective outcomes with biofeedback or verbal feedback .
Weight loss with diet and exercise , caffeine reduction , 25 - 50 % reduction in fluid intake , and pelvic floor muscle exercises with verbal instruction and or biofeedback were all efficacious .
Botulinum toxin A improves urge incontinence episodes , urgency , frequency , quality of life , nocturia , and urodynamic testing parameters .
Acupuncture  improves quality of life and urodynamic testing parameters .
Extracorporeal magnetic stimulation improves urodynamic parameters .
Mirabegron improves daily incontinence episodes , nocturia , number of daily voids , and urine volume per void , whereas solabegron improves daily incontinence episodes .
Short-term posterior tibial nerve stimulation is more efficacious than pelvic floor muscle training exercises and behavioral therapy for improving : urgency , urinary incontinence episodes , daily voids , volume per void , and overall quality of life .
Sacral neuromodulation is more efficacious than antimuscarinic treatment for subjective improvement of overactive bladder and quality of life .
Transvaginal electrical stimulation demonstrates subjective improvement in overactive bladder symptoms and urodynamic parameters .
Multiple therapies , including physical therapy , behavioral therapy , botulinum toxin A , acupuncture , magnetic stimulation , mirabegron , posterior tibial nerve stimulation , sacral neuromodulation , and transvaginal electrical stimulation , are efficacious in the treatment of overactive bladder
The purpose of the study was to determine the efficacy and safety of nonantimuscarinic treatments for overactive bladder .
Effect of weight loss on urinary incontinence in overweight and obese women: results at 12 and 18 months.
PURPOSE Initial weight loss improves urinary incontinence in overweight and obese women . In this study we examined the longer term effects of a weight loss intervention on urinary incontinence . MATERIAL S AND METHODS Overweight and obese women ( mean + /- SD age 53 + /- 10 years ) with 10 or more urinary incontinence episodes weekly were r and omized to an 18-month behavioral weight loss intervention ( 226 ) or control group ( 112 ) . Outcome measures were collected at 12 and 18 months . RESULTS At baseline women had a mean body mass index of 36 + /- 6 kg/m(2 ) and reported a mean of 24 + /- 18 incontinence episodes weekly . Of the patients 86 % completed 18-month measurements . The percent weight loss in the intervention group averaged 8.0 % , 7.5 % and 5.5 % at 6 , 12 and 18 months , respectively , vs approximately 1.5 % in the control group ( all values p < 0.001 ) . Compared with controls at 12 months the intervention group reported a greater percent reduction in weekly stress urinary incontinence episodes ( 65 % vs 47 % , p < 0.001 ) , and a greater proportion achieved at least a 70 % decrease in weekly total and stress urinary incontinence episodes . At 18 months a greater proportion of women in the weight loss intervention group had more than 70 % improvement in urge incontinence episodes but there were no significant differences between the groups for stress or total urinary incontinence . The intervention group also reported greater satisfaction with changes in urinary incontinence than the control group at 6 , 12 and 18 months . CONCLUSIONS Weight loss intervention reduced the frequency of stress incontinence episodes through 12 months and improved patient satisfaction with changes in incontinence through 18 months . Improving weight loss maintenance may provide longer term benefits for urinary incontinence
Pelvic floor exercises are more effective in subjective and objective outcomes with biofeedback or verbal feedback .
Weight loss with diet and exercise , caffeine reduction , 25 - 50 % reduction in fluid intake , and pelvic floor muscle exercises with verbal instruction and or biofeedback were all efficacious .
Botulinum toxin A improves urge incontinence episodes , urgency , frequency , quality of life , nocturia , and urodynamic testing parameters .
Acupuncture  improves quality of life and urodynamic testing parameters .
Extracorporeal magnetic stimulation improves urodynamic parameters .
Mirabegron improves daily incontinence episodes , nocturia , number of daily voids , and urine volume per void , whereas solabegron improves daily incontinence episodes .
Short-term posterior tibial nerve stimulation is more efficacious than pelvic floor muscle training exercises and behavioral therapy for improving : urgency , urinary incontinence episodes , daily voids , volume per void , and overall quality of life .
Sacral neuromodulation is more efficacious than antimuscarinic treatment for subjective improvement of overactive bladder and quality of life .
Transvaginal electrical stimulation demonstrates subjective improvement in overactive bladder symptoms and urodynamic parameters .
Multiple therapies , including physical therapy , behavioral therapy , botulinum toxin A , acupuncture , magnetic stimulation , mirabegron , posterior tibial nerve stimulation , sacral neuromodulation , and transvaginal electrical stimulation , are efficacious in the treatment of overactive bladder
The purpose of the study was to determine the efficacy and safety of nonantimuscarinic treatments for overactive bladder .